CSF2 and inflammatory bowel disease: Together with earlier reports of anti-GM-CSF autoantibodies as a marker of severity in IBD8 and anti-integrin αvβ6 autoantibodies in advance of UC development20, our findings highlight the potential contribution of humoral autoimmunity to the multifactorial pathogenesis of IBD and raise the possibility of humorally targeted therapy in selected individuals.